Neuronetics, Inc., is a privately held medical device company focused on developing non-invasive therapies for psychiatric and neurological disorders using MRI-strength magnetic field pulses. Based in Malvern, PA, Neuronetics is the leader in the development of TMS Therapy, a non-invasive form of neuromodulation.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/27/15 | $34,000,000 | Series F |
Accuitive Medical Ventures GE Ventures InterWest Partners KBL Healthcare Ventures New Leaf Venture Partners ONSET Ventures Pfizer Strategic Investments Group Polaris Partners Quaker BioVentures | undisclosed |
| 06/06/17 | $15,000,000 | Series G |
Accuitive Medical Ventures Ascension Health Ventures GE Ventures Industry Ventures InterWest Partners Investor Growth Capital KBL Healthcare Ventures New Leaf Venture Partners ONSET Ventures Pfizer Strategic Investments Group Polaris Partners | undisclosed |
